v3.25.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 398 $ 272
Accounts and notes receivable-trade, net 604 556
Inventories, net 612 564
Prepaid expenses and other current assets 364 354
Total Current Assets 1,978 1,746
Property, plant, and equipment, net 791 766
Operating lease right-of-use assets, net 133 136
Identifiable intangible assets, net 1,212 1,207
Goodwill 1,632 1,597
Other noncurrent assets 304 301
Total Assets 6,050 5,753
Current Liabilities:    
Accounts payable 276 241
Accrued liabilities 738 754
Income taxes payable 37 45
Notes payable and current portion of long-term debt 742 549
Total Current Liabilities 1,793 1,589
Long-term debt 1,593 1,586
Operating lease liabilities 88 91
Deferred income taxes 134 129
Other noncurrent liabilities 432 415
Total Liabilities 4,040 3,810
Commitments and contingencies (Note 14)
Equity:    
Preferred stock, $1.00 par value; 0.25 million shares authorized; no shares issued 0 0
Common stock, $0.01 par value; 400.0 million shares authorized, and 264.5 million shares issued at March 31, 2025 and December 31, 2024 and December 31, 2023, 198.8 million and 207.2 million shares outstanding at March 31, 2025 and December 31, 2024 3 3
Capital in excess of par value 6,631 6,640
Accumulated deficit (848) (835)
Accumulated other comprehensive loss (659) (730)
Treasury stock, at cost, 65.2 million and 65.7 million shares at March 31, 2025 and December 31, 2024, respectively (3,117) (3,136)
Total Dentsply Sirona Equity 2,010 1,942
Noncontrolling interests 0 1
Total Equity 2,010 1,943
Total Liabilities and Equity $ 6,050 $ 5,753